UCB PHARMA SA
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Public, Subsidiary
- Established
- 1928-01-01
- Employees
- 9K
- Market Cap
- $34.9B
Efficacy and Safety of Levetiracetam in Routine Clinical Practice in Czech and Slovak Republics, Hungary, and Romania.
Completed
- Conditions
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2012-05-28
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 2569
- Registration Number
- NCT00614549
Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)
Phase 2
Completed
- Conditions
- First Posted Date
- 2008-02-12
- Last Posted Date
- 2013-11-26
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 217
- Registration Number
- NCT00612859
Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures
Phase 2
Completed
- Conditions
- First Posted Date
- 2008-02-08
- Last Posted Date
- 2013-12-06
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 25
- Registration Number
- NCT00610454
Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method
Phase 2
Completed
- Conditions
- First Posted Date
- 2008-01-25
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 216
- Registration Number
- NCT00600509
Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional Study
Completed
- Conditions
- First Posted Date
- 2008-01-23
- Last Posted Date
- 2012-05-28
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 7870
- Registration Number
- NCT00598780
- Locations
- 🇺🇸
UCB Pharma, Smyrna, Georgia, United States
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease
- First Posted Date
- 2008-01-23
- Last Posted Date
- 2014-10-02
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 381
- Registration Number
- NCT00599196
Transdermal Rotigotine User Surveillance Study
Completed
- Conditions
- First Posted Date
- 2008-01-23
- Last Posted Date
- 2018-08-09
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 2195
- Registration Number
- NCT00599339
- Locations
- 🇷🇴
407, Bacau, Romania
🇷🇴423, Bucharest, Romania
🇸🇰502, Bratislava, Slovakia
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease
- First Posted Date
- 2008-01-15
- Last Posted Date
- 2014-10-02
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 258
- Registration Number
- NCT00594386
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.
- First Posted Date
- 2008-01-15
- Last Posted Date
- 2014-10-02
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 217
- Registration Number
- NCT00594165
A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery
- First Posted Date
- 2008-01-15
- Last Posted Date
- 2014-10-02
- Lead Sponsor
- UCB Pharma
- Target Recruit Count
- 14
- Registration Number
- NCT00594464
© Copyright 2024. All Rights Reserved by MedPath